PharmacyCodes



Tiagabinum [Inn-Latin] en es it fr

Tiagabinum [Inn-Latin] Brand names, Tiagabinum [Inn-Latin] Analogs

Tiagabinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Tiagabinum [Inn-Latin] Chemical_Formula

C20H25NO2S2

Tiagabinum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/gabitril.htm

Tiagabinum [Inn-Latin] fda sheet

Tiagabinum_[Inn-Latin] FDA

Tiagabinum [Inn-Latin] msds (material safety sheet)

Tiagabinum [Inn-Latin] Synthesis Reference

No information avaliable

Tiagabinum [Inn-Latin] Molecular Weight

375.55 g/mol

Tiagabinum [Inn-Latin] Melting Point

No information avaliable

Tiagabinum [Inn-Latin] H2O Solubility

No information avaliable

Tiagabinum [Inn-Latin] State

Solid

Tiagabinum [Inn-Latin] LogP

3.417

Tiagabinum [Inn-Latin] Dosage Forms

No information avaliable

Tiagabinum [Inn-Latin] Indication

For the treatment of partial seizures

Tiagabinum [Inn-Latin] Pharmacology

Tiagabine is used primarily as an anticonvulsant for the adjunctive treatment of epilepsy. The precise mechanism by which Tiagabine exerts its antiseizure effect is unknown, although it is believed to be related to its ability to enhance the activity of gamma aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. Tiagabine binds to recognition sites associated with the GABA uptake carrier. It is thought that, by this action, Tiagabine blocks GABA uptake into presynaptic neurons, permitting more GABA to be available for receptor binding on the surfaces of post-synaptic cells.

Tiagabinum [Inn-Latin] Absorption

Tiagabine is nearly completely absorbed (>95%).

Tiagabinum [Inn-Latin] side effects and Toxicity

No information avaliable

Tiagabinum [Inn-Latin] Patient Information

No information avaliable

Tiagabinum [Inn-Latin] Organisms Affected

Humans and other mammals